Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
38 hedge funds and large institutions have $5.8M invested in Tobira Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.
19% more capital invested
Capital invested by funds: $4.89M → $5.8M (+$914K)
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
7% less funds holding
Funds holding: 41 → 38 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$268K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$265K |
| 3 |
State Street
Boston,
Massachusetts
|
+$27.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.7K |
| 5 |
Renaissance Technologies
New York
|
+$26.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.21M |
| 2 |
Morgan Stanley
New York
|
-$46.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$39K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$33K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$15K |
TBRA Hedge Fund Activity: Q1 2015 in Review
38 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q1 2015, worth a combined $5.8M — up 19% from $4.89M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of TBRA and 6 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was Polar Capital, opening a new position worth an estimated $268K. The largest seller was Panagora Asset Management, cutting an estimated $1.21M.
- 38 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q1 2015, down from 41 in Q4 2014.
- Funds reported $5.8M of Tobira Therapeutics, Inc. Common Stock stock for Q1 2015, up 19% quarter-over-quarter.
- 6 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q1 2015 and 9 closed out, a net change of -3 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q1 2015 was Polar Capital, an estimated $268K added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q1 2015 was Panagora Asset Management, an estimated $1.21M sold.
Based on aggregated 13F filings for Q1 2015.